Journal News

When things get SAPpy: Novel insights into complement

Lydia Smith
March 20, 2026

The body uses two distinct arms of the immune system to effectively fight off various pathogens, such as bacteria and viruses. The innate immune system is considered the “first responder” and includes the complement system. This system is a key regulator of inflammatory signal amplification and clearance of dead or damaged cells to manage pathogenic infections.

The image shows a structural model of C4BP higher-order structure with multiple C4BP-α (grey).

C4BP is a binding protein responsible for the inactivation of complement protein C4b and, consequently, the complement cascade. Interestingly, C4BP is also known to form higher-order structures, or HOS, allowing C4BP to interact with other complement-related proteins. Recently, Tereza Kadavá and a team of scientists at Utrecht University characterized the interactions of C4BP HOS with two of its known binding partners, C4b and serum amyloid protein, or SAP, and identified potential areas of crosstalk between the two binding interactions. The study was published in Molecular & Cellular Proteomics.

Using a combination of mass photometry and high-speed atomic force microscopy, the team determined that C4b formed three different types of complexes with C4BP HOS particles. The most abundant binding conformation consisted of a 1:1 C4BP:C4b binding ratio, while smaller quantities of complexes were bound in ratios of 1:2 or 1:3. Additionally, they determined that these interactions are specifically mediated by C4BP-α chains within the C4BP structure.

Conversely, SAP showed a strong preference for 1:1 binding ratios, which led to the discovery of SAP pentamer engagement with the entire C4BP HOS. By using cross-linking mass spectrometry, Kadavá and her colleagues discovered that SAP interacts with the C4BP HOS via the C4BP oligomerization core. The researchers also noticed that even in the presence of abundant C4BP-α, C4BP-SAP complex formation did not occur, suggesting that this process is mediated separately from C4BP:C4b binding.

This work provides novel proteomic insights into the complement cascade and structurally defines the C4BP-C4b complex for the first time.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Lydia Smith

Lydia Smith has a B.S. in molecular cell biology and a minor in chemistry, which she received from California State University, Long Beach. She is continuing on to receive her Ph.D. in microbiology and immunology at the University of Utah and is a volunteer contributor for ASBMB Today. 

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Light-activated small molecule could transform eye infection treatment
News

Light-activated small molecule could transform eye infection treatment

April 21, 2026

Contact lenses raise the risk of infectious keratitis, a leading cause of blindness worldwide. A biotech company is commercializing a light-activated therapy using a ROS-generating molecule to rapidly kill microbes in the cornea to preserve vision.

The molecular orchestra of memory
Feature

The molecular orchestra of memory

April 16, 2026

Calcium, calmodulin and calcium/calmodulin-dependent kinase II form a molecular axis that turns fleeting neural activity into lasting memories. New research shows how memories are stabilized, and possibly even protected or repaired.

Differences in pili structure modulate bacterial behavior
Journal News

Differences in pili structure modulate bacterial behavior

April 14, 2026

Researchers demonstrate how small changes in the structure of hair-like protein appendages can affect the behavior of Acinetobacter bacteria.

Cholesterol regulatory genes predict liver transplant outcomes
Journal News

Cholesterol regulatory genes predict liver transplant outcomes

April 10, 2026

Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Journal News

Lipid signatures for a rare neurological disorder

April 10, 2026

Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Journal News

Disease-linked mutations disrupt protein phase behavior

April 9, 2026

Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.